Sarah S. Kalia ScM, Kathy Adelman, Sherri J. Bale PhD, Wendy K. Chung MD, PhD, Christine Eng MD, James P. Evans MD, PhD, Gail E. Herman MD, PhD, Sophia B. Hufnagel MD, Teri E. Klein PhD, Bruce R. Korf MD, PhD, Kent D. McKelvey MD, Kelly E. Ormond MS, C. Sue Richards PhD, Christopher N. Vlangos PhD, Michael Watson PhD, Christa L. Martin PhD and David T. Miller MD, PhD ; on behalf of the ACMG Secondary Findings Maintenance Working Group
Genet Med advance online publication, November 17, 2016; doi:10.1038/gim.2016.190
In the published version of this article, Table 1 contained errors in the “Variants to report” column for some genes in the “Hypertrophic cardiomyopathy, dilated cardiomyopathy” and “Arrhythmogenic right ventricular cardiomyopathy” sections. Those errors have been corrected. The corrected table appears below.
Additional information
The online version of the original article can be found at 10.1038/gim.2016.190
Rights and permissions
About this article
Cite this article
Correction: Corrigendum: Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 19, 484 (2017). https://doi.org/10.1038/gim.2017.17
Published:
Issue Date:
DOI: https://doi.org/10.1038/gim.2017.17
This article is cited by
-
An spanish study of secondary findings in families affected with mendelian disorders: choices, prevalence and family history
European Journal of Human Genetics (2023)
-
Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies
Modern Pathology (2022)
-
Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity
European Journal of Human Genetics (2022)
